eli lilly sues compounders for selling unapproved copies of tirzepatide finds impurity in compounded Lilly finds impurity in compounded

doi:10.1111/apt.18331 Wegovy (semaglutide) injection [package insert]

(2025) 17:e78050

If you're a ReadyRx member on a GLP-1 program, the company offers unlimited physician messaging, which may be an appropriate channel to discuss NAD+ with your provider

This could be of clinical relevance because retatrutide has entered at least ten clinical studies (at clinicaltrials.gov, at the day of this writing)

Some plan sponsors have chosen to require biosimilar switches as soon as alternatives are available, and Medavie has supported those decisions with an in-house patient navigator who walks members through the transition